ATTENTION ALL CUSTOMERS:
Due to a recent change in our pharmacy software system, all previous login credentials will no longer work.
Please click on “Sign Up Today!” to create a new account, and be sure to download our NEW Mobile app!
Thank you for your patience during this transition.
Results of a phase 3 clinical trial show an experimental drug called tolebrutinib can delay disability in patients with non-relapsing secondary progressive multiple sclerosis.